Biotech stocks have been hammered in 2021 and so far into 2022 despite the focus on drug development that has accompanied the 2 years of COVID 19 therapy development. These biotech stock research ...

John Vandermosten is a senior biotechnology research analyst for Zacks SCR where he covers a portfolio of biotech IPO and small-cap equities. His background includes 20 years of experience in a ...

The biotech sector has been surging in recent months, reawakening from a period of underperformance that followed the 2021 highs. "I look for wherever I can make the most amount of money, legally, ...

The biotech-focused Perceptive Advisors and its hedge fund, Perceptive Life Sciences, recently made big changes in its portfolio after strong performances.

So, you want to get into biotech? Whether you or a young person in your life are looking for the best high school pathways, undergrad pathways, community college programs, advanced degrees or ...

PRO Steering Committee of clinical trial subject recruitment and retention firms, is pleased to announce that Robert Loll is the newly elected Vice Chairman of the committee. Date Released: 07/16/2010 ...

Currently available chronic kidney disease therapies can slow the condition’s progression, but they can’t stop the decline in organ function. Regenerative medicine company ProKidney is offering the ...

BiotechXBeautyLabs™ now creates specialized, clinically-backed products for professional beauty services including skincare studios, facial bars and med-spas. SAN DIEGO, Nov. 12, 2024 /PRNewswire/ -- ...

Biotechnology is a rapidly growing sector of the United States and global economies. Its products are increasingly important in diagnosis, prevention, and treatment of disease. Visit the Professional ...

Phase 1 clinical trial designed to assess the safety, pharmacokinetics and preliminary efficacy of VIR-5525 alone or in combination with pembrolizumab in a variety of EGFR-expressing solid tumors such ...